FINWIRES — Financial News

JPMorgan Upgrades Eastman Chemical to Overweight From Neutral, Raise Price Target to $80 From $70

Eastman Chemical (EMN) has an average rating of overweight and mean price target of $77.27, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Financial News · Live Terminal

JPMorgan Upgrades Eastman Chemical to Overweight From Neutral, Raise Price Target to $80 From $70

Scotiabank Initiates Janus Living at Sector Outperform With $28 Price Target

William Blair Initiates Natera at Outperform

BNP Paribas Initiates Janus Living at Outperform With $27 Price Target

Seaport Global Securities Upgrades Crocs to Buy From Neutral, $135 Price Target

Evercore ISI Initiates ADTRAN Holdings at Outperform With $18 Price Target

Seaport Global Securities Upgrades Birkenstock to Buy From Neutral, $52 Price Target

Piper Sandler Initiates Adagio Medical at Overweight With $3 Price Target

Citigroup Initiates Infleqtion at Buy With $20 Price Target

Raymond James Initiates Equillium at Strong Buy With $6 Price Target

BNP Paribas Initiates Lennox International at Neutral With $535 Price Target

BNP Paribas Initiates Carrier Global at Neutral With $62 Price Target

BNP Paribas Initiates Vertiv Holdings at Outperform With $345 Price Target

BNP Paribas Initiates Johnson Controls International at Underperform With $120 Price Target

BNP Paribas Initiates Trane Technologies at Outperform With $550 Price Target

RBC Downgrades NOV to Sector Perform From Outperform, Keeps $21 Price Target

RBC Initiates Charles River Laboratories International at Outperform With $215 Price Target

RBC Initiates Janus Living at Outperform With $27 Price Target

KeyBanc Initiates Janus Living at Overweight With $28 Price Target

Morgan Stanley Initiates Janus Living at Overweight With $28 Price Target

JPMorgan Upgrades Eastman Chemical to Overweight From Neutral, Raise Price Target to $80 From $70

Scotiabank Initiates Janus Living at Sector Outperform With $28 Price Target

William Blair Initiates Natera at Outperform

BNP Paribas Initiates Janus Living at Outperform With $27 Price Target

Seaport Global Securities Upgrades Crocs to Buy From Neutral, $135 Price Target

Evercore ISI Initiates ADTRAN Holdings at Outperform With $18 Price Target

Seaport Global Securities Upgrades Birkenstock to Buy From Neutral, $52 Price Target

Piper Sandler Initiates Adagio Medical at Overweight With $3 Price Target

Citigroup Initiates Infleqtion at Buy With $20 Price Target

Raymond James Initiates Equillium at Strong Buy With $6 Price Target

BNP Paribas Initiates Lennox International at Neutral With $535 Price Target

BNP Paribas Initiates Carrier Global at Neutral With $62 Price Target

BNP Paribas Initiates Vertiv Holdings at Outperform With $345 Price Target

BNP Paribas Initiates Johnson Controls International at Underperform With $120 Price Target

BNP Paribas Initiates Trane Technologies at Outperform With $550 Price Target

RBC Downgrades NOV to Sector Perform From Outperform, Keeps $21 Price Target

RBC Initiates Charles River Laboratories International at Outperform With $215 Price Target

RBC Initiates Janus Living at Outperform With $27 Price Target

KeyBanc Initiates Janus Living at Overweight With $28 Price Target

Morgan Stanley Initiates Janus Living at Overweight With $28 Price Target